/
RSS Feed
Ross Davidson
Ross Davidson, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
The use of the antimalarial chloroquine could provide the selective pressure for E.coli to develop fluoroquinolone resistance – that’s according to a study presented by Ross Davidson at ICAAC. He investigated this by looking at remote community from Guyana, who had access to chloroquine but not fluoroquinolones, and he began by telling Audio Medica about the link between the two.
[audio:https://www.audiomedica.com/podcasting/icaac2005/ross_davidson.mp3]
